The Role of Inflammatory Markers in Sepsis
International Journal of Drug Delivery Technology · 08.08.2026 · 16 (73s)
DOI: 10.25258/ijddt.16.73s.128 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 08.08.2026. Verfasst von Moustafa Ragab Lokai und 3 weiteren Autor:innen.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis is a life-threatening condition caused by a dysregulated response to infection that can lead to multiple organ dysfunction and death. Early diagnosis remains difficult because the clinical presentation is often nonspecific. Inflammatory biomarkers have become important tools for supporting diagnosis, assessing disease severity, and monitoring treatment response.
Aim
To review the current evidence on inflammatory biomarkers used in sepsis, with emphasis on their pathophysiological basis and clinical applications. Subjects and Methods: A narrative review of the published literature was conducted to summarize the mechanisms of inflammatory marker release in sepsis and to evaluate the clinical value of commonly used and emerging biomarkers for diagnosis, prognosis, and treatment monitoring.
Results
Conventional biomarkers, including C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), remain widely used in clinical practice. Emerging biomarkers such as presepsin, lactate, plasma renin, ICAM-1, VEGFR2, and urokinase-type plasminogen activator (uPA) provide additional information regarding disease severity, septic shock, and patient outcomes. Current evidence suggests that combining biomarkers with clinical evaluation and severity scoring systems provides better diagnostic and prognostic performance than relying on a single marker.
Conclusion
Inflammatory biomarkers support many aspects of sepsis management, including diagnosis, risk assessment, treatment monitoring, and antibiotic stewardship. Their interpretation should always be considered alongside clinical findings, microbiological results, and established scoring systems to improve patient assessment.
Zitieren
APA
Lokai, M. R., Abbas, I., Zekri, J., & Mousa, S. O. (2026). The Role of Inflammatory Markers in Sepsis. International Journal of Drug Delivery Technology, 16(73s). https://doi.org/10.25258/ijddt.16.73s.128
Vancouver
Lokai MR, Abbas I, Zekri J, Mousa SO. The Role of Inflammatory Markers in Sepsis. International Journal of Drug Delivery Technology. 2026;16(73s). doi:10.25258/ijddt.16.73s.128
BibTeX
@article{Lokai2026,
author = {Lokai, Moustafa Ragab and Abbas, Ibrahim and Zekri, Josef and Mousa, Sarah Omar},
title = {The Role of Inflammatory Markers in Sepsis},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {73s},
doi = {10.25258/ijddt.16.73s.128}
}
EUVIMED